Skip to main content

Want a detailed portfolio tracker?

BioCardia (BCDA) P/E (2013 - 2026)

BioCardia (BCDA) P/E from Sep 12, 2013 to Jun 2, 2026. The TTM BioCardia (BCDA) P/E is -0.69. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioCardia (BCDA)

YearP/EChange
2026-0.69-18.10%
2025-0.85+45.42%
2024-0.58-47.27%
2023-1.10-85.25%
2022-7.49+7.73%
2021-6.95-43.93%
2020-12.40-2.80%
2019-12.76-58.23%
2018-30.55-61.95%
2017-80.30+340.65%
2016-18.22+562.46%
2015-2.75-102.62%
2014105.18-83.70%
2013645.08N/A

Comparison BioCardia (BCDA) P/E with competitors

BioCardia (BCDA) P/E is -0.69.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.24%
NBYStablecoin Development Corp0.10-114.73%
ENLVEnlivex Therapeutics Ltd0.15-121.65%
FGENFibroGen Inc0.24-134.59%
TRAWTraws Pharma Inc0.47-168.13%
FBIOFortress Biotech Inc0.71-201.74%
CHRSCoherus Biosciences Inc0.98-240.95%
ORMPOramed Pharmaceuticals Inc1.47-312.33%
AGENAgenus Inc2.05-395.19%
VIVSVivoSim Labs Inc2.54-465.42%
INVAInnoviva Inc3.19-559.48%
CRMDCorMedix Inc3.65-625.37%
ABEOAbeona Therapeutics Inc4.20-705.97%
VXRTVaxart Inc4.26-714.12%
CVACCureVac N.V.4.45-740.64%
SRPTSarepta Therapeutics Inc4.62-766.38%
GLPGGalapagos NV4.86-800.18%
RIGLRigel Pharmaceuticals4.92-808.93%
ZVRAZevra Therapeutics Inc4.97-816.79%
ABUSArbutus Biopharma Corp5.69-920.50%
CGENCompugen Ltd7.38-1164.08%
AUPHAurinia Pharmaceuticals Inc9.25-1433.20%
ACADAcadia Pharmaceuticals Inc9.59-1481.71%
OMEROmeros Corporation9.88-1524.28%
PLXProtalix BioTherapeutics Inc9.91-1527.98%
SPROSpero Therapeutics Inc10.73-1646.96%
ADMAAdma Biologics Inc11.33-1732.83%
SVASinovac Biotech Ltd11.44-1748.02%
TBPHTheravance Biopharma Inc11.78-1797.11%
HRMYHarmony Biosciences Holdings Inc12.18-1855.30%
TGTXTG Therapeutics Inc13.18-1999.26%
INCYIncyte Corp13.38-2028.46%
SABSSAB Biotherapeutics Inc14.06-2125.83%
XOMAXOMA Corp14.95-2253.73%
REGNRegeneron Pharmaceuticals Inc14.98-2258.77%
PBYIPuma Biotechnology Inc15.05-2268.89%
EXELExelixis Inc15.79-2376.17%
NAGENiagen Bioscience Inc16.35-2456.88%
CPRXCatalyst Pharmaceuticals Inc17.34-2599.52%
MDXGMimedx Group Inc17.38-2603.93%
ARGXArgen X SE23.07-3424.81%
HALOHalozyme Therapeutics Inc23.20-3443.40%
XOMAOXOMA Corp25.34-3752.40%
VRTXVertex Pharmaceuticals Inc25.66-3797.22%
XOMAPXOMA Corp25.67-3799.28%
CTMXCytomX Therapeutics Inc25.70-3803.28%
ASNDAscendis Pharma A/S26.35-3897.85%
RPRXRoyalty Pharma plc - Class A27.50-4062.32%
SLNOSoleno Therapeutics Inc29.02-4281.35%
LGNDLigand Pharmaceuticals Inc - Class B30.19-4450.13%
BMRNBiomarin Pharmaceutical Inc37.51-5505.12%
APLSApellis Pharmaceuticals Inc39.02-5723.28%
KRYSKrystal Biotech Inc39.70-5820.76%
GMABGenmab40.20-5893.68%
ONCBeiGene Ltd67.03-9759.16%
TECHBio-Techne Corp68.59-9985.13%
VCELVericel Corp80.63-11719.36%
PHARPharming Group N.V.87.74-12744.11%
ALNYAlnylam Pharmaceuticals Inc124.93-18104.02%
TLXTelix Pharmaceuticals Ltd139.89-20259.45%
CORTCorcept Therapeutics Inc158.39-22925.26%